Remarkable Response to Ceritinib and Brigatinib in an Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma Previously Treated with Crizotinib

Thyroid. 2020 Feb;30(2):343-344. doi: 10.1089/thy.2019.0202.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Organophosphorus Compounds / therapeutic use*
  • Pyrimidines / therapeutic use*
  • Sulfones / therapeutic use*
  • Thyroid Carcinoma, Anaplastic / diagnostic imaging
  • Thyroid Carcinoma, Anaplastic / drug therapy*
  • Thyroid Carcinoma, Anaplastic / genetics
  • Thyroid Neoplasms / diagnostic imaging
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / genetics
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Organophosphorus Compounds
  • Pyrimidines
  • Sulfones
  • brigatinib
  • ceritinib